Ropivakain BioQ Pharma 2 mg/ml otopina za infuziju u sustavu za primjenu
| Name | Ropivakain BioQ Pharma 2 mg/ml otopina za infuziju u sustavu za primjenu |
|---|---|
| Marketing Authorisation Number | HR-H-530257257 |
| Active Substance | ropivakainklorid hidrat |
| Composition | 1 ml otopine za infuziju sadrži ropivakainklorid hidrat što odgovara 2 mg ropivakainklorida |
| Pharmaceutical Form | otopina za infuziju u sustavu za primjenu |
| Manufacturer | Geryon Pharma Ltd, Liverpool, Ujedinjeno Kraljevstvo;
BioQ Pharma B.V., Amsterdam, Nizozemska |
| Marketing Authorisation Holder | BioQ Pharma B.V., Prins Bernhardplein 200, Amsterdam, Nizozemska |
| Marketing Authorisation Date | 15.03.2019 |
| MA Period of Validity | 21.12.2022 |
| Classification Number | UP/I-530-09/15-01/84 |
| Registration Number | 381-12-01/70-19-22 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N01BB09 |
| Medicinal product marketed in the Croatia | Trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
